Science Explorer Back to mapMap

Most cited papers from Nevada Cancer Research Foundation

What are the most cited papers from Nevada Cancer Research Foundation?

The most cited paper from Nevada Cancer Research Foundation is "Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial" (Manish R. Patel, John Allan Ellerton, Jeffrey R. Infante et al., 2017), with 591 citations. Next come "Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma" (582) and "Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies" (252).

Showing 15 of 15 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial Manish R. Patel, John Allan Ellerton, Jeffrey R. Infante et al. · The Lancet Oncology Open access 5 Dec 2017 591
2 Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma W. C. Wood, Daniel R. Budman, Ann H. Korzun et al. · New England Journal of Medicine Open access 5 May 1994 582
3 Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies Gwénaëlle Gravis, Jean‐Marie Boher, Yu‐Hui Chen et al. · European Urology Open access 21 Feb 2018 252
4 Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment Erika E. Ramsdale, Mostafa Mohamed, Veronica Yu et al. · The Oncologist Open access Mar 2022 92
5 Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis Andrea Borghese Apolo, John Allan Ellerton, Jeffrey R. Infante et al. · Journal for ImmunoTherapy of Cancer Open access Oct 2020 84
6 Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial Alan Haruo Bryce, Yu‐Hui Chen, Glenn Liu et al. · European Urology Oncology Open access 15 Aug 2020 40
7 Biomarkers in renal cell carcinoma: Are we there yet? Shuchi Gulati, Nicholas J. Vogelzang · Asian journal of urology Open access 6 Jun 2021 27
8 Using Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced Cancer Amber S. Kleckner, Megan Wells, Lee A. Kehoe et al. · JCO Oncology Practice Open access 6 Jul 2021 17
9 Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin e1 analog misoprostol (RTOG 96-07) Darlene J. Johnson, Charles Scott, James E. Marks et al. · International Journal of Radiation Oncology*Biology*Physics Dec 2002 15
10 Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524—A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation Douglas M. Dahl, Theodore G Karrison, Marc Dror Michaelson et al. · European Urology Oncology Open access 11 Jul 2023 13
11 Carboplatin and vinblastine in advanced non-small-cell lung cancer: a phase II study D C Doll, Maria Goutsou, Stephen L. Graziano et al. · Cancer Chemotherapy and Pharmacology 1991 5
12 Association Between Caregiver-Oncologist Discordance in Patient's Life Expectancy Estimates and Caregiver Perceived Autonomy Support by the Oncologist Gina Tuch, Chandrika Sanapala, Supriya Gupta Mohile et al. · The Oncologist Open access 26 Jul 2021 4
13 The scientific data audit system of the cancer and leukemia group B (CALGB) Raymond B. Weiss, Nicholas J. Vogelzang, Bruce A. Peterson et al. · Accountability in Research 1992 4
14 Exploring decisional control preferences in older patients with cancer and their caregivers Sofiia Hryniv, Elizabeth Gilbride, William Consagra et al. · Journal of Geriatric Oncology Open access 12 Dec 2025 1
15 Assessment of quality of life and oral function of patients participating in a phase II study of radioprotection of oral and pharyngeal mucosa by the prostaglandin E1 analoge misoprostol (Rtog 96-07) Darryl Johnson, Charles Scott, Joe Marks et al. · International Journal of Radiation Oncology*Biology*Physics Open access Nov 2001 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.